CD4 and neoplasm: In the majority of our previous experiments, the MATE trimer seemed to show a more favorable profile regarding the quality of T-cell activation such as the CD8/CD4 T cell ratio, triggering of tumor-specific T cells and a higher number of PD1-positive cells within the tumor.